Cancer VaccinesVaccinesMedical OncologyVaccines, InactivatedVaccines, DNAViral VaccinesVaccines, SyntheticVaccines, SubunitVaccines, CombinedBacterial VaccinesNeoplasmsAntigens, NeoplasmOncology NursingImmunotherapyImmunotherapy, ActiveAIDS VaccinesVaccinationPapillomavirus VaccinesVaccines, ConjugateClinical Trials as TopicRadiation OncologyAdjuvants, ImmunologicMalaria VaccinesOncology Service, HospitalDendritic CellsMonitoring, ImmunologicMeningococcal VaccinesMice, Inbred BALB CProstatic NeoplasmsHepatitis B VaccinesLung NeoplasmsT-Lymphocytes, CytotoxicEarly Detection of CancerBreast NeoplasmsMeasles VaccineAntigens, Tumor-Associated, CarbohydrateBCG VaccinePertussis VaccineCD8-Positive T-LymphocytesHaemophilus VaccinesMelanoma, ExperimentalPoliovirus Vaccine, InactivatedRabies VaccinesOvarian NeoplasmsMelanomaRotavirus VaccinesAntineoplastic AgentsCholera VaccinesCombined Modality TherapyCell Line, Tumorgp100 Melanoma AntigenImmunizationColonic NeoplasmsUterine Cervical NeoplasmsTreatment OutcomeSurvival AnalysisMice, Inbred C57BLTyphoid-Paratyphoid VaccinesSmallpox VaccineNeoplasm MetastasisNeoplasm ProteinsAntibodies, ViralTuberculosis VaccinesEpitopes, T-LymphocyteChickenpox VaccineDiphtheria-Tetanus-Pertussis VaccineAntibodies, NeoplasmAntineoplastic Combined Chemotherapy ProtocolsT-LymphocytesMumps VaccineGenetic VectorsHepatitis A VaccinesImmunization ScheduleImmunization, SecondaryClinical Trials, Phase III as TopicReceptor, erbB-2HLA-A2 AntigenMeasles-Mumps-Rubella VaccineUnited StatesStreptococcal VaccinesAnthrax VaccinesDengue VaccinesAluminum HydroxideStomach NeoplasmsVaccines, VirosomeCD4-Positive T-LymphocytesLymphocyte ActivationMolecular Sequence DataGlycoconjugatesPrognosisSurvival RateEnzyme-Linked Immunosorbent AssayInjections, IntradermalImmunoglobulin GInterferon-gammaMucin-1Viral Hepatitis VaccinesDrug ApprovalPoliovirus Vaccine, OralAntibodies, Monoclonal